Study of STRO-004 for advanced solid tumors
Treatments studied
Part of Cancer, Digestive system, Women’s health & pregnancy clinical trials.
This trial tests a new drug called STRO-004 for people with advanced solid tumors (cancers that have spread or come back). It aims to see if the drug is safe and effective for those who have already tried other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumor that has spread or is advanced, such as head and neck, lung, esophageal, stomach, colorectal, pancreatic, cervical, endometrial, or bladder cancer.
- You are 18 years or older.
- You are well enough to be up and about (ECOG score 0 or 1).
- You have tried all standard treatments that are available to you. For some groups, there is no limit on prior treatments; for others, up to 3 prior treatments are allowed.
- You have tumor tissue available for testing and a tumor that can be measured on scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called PHST001 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and if it can help shrink tumors.
This trial tests a new medicine, PF-08046876, for people with advanced cancers of the bladder, lung, head and neck, esophagus, or pancreas. It aims to see if the drug is safe and works against these cancers.
This trial tests a new drug, ST-01156, designed to attack cancer cells by breaking down a protein called RBM39. It may be an option for people with advanced solid tumors that have not responded to other treatments.
This study tests an experimental drug called STX-1, given alone or with another drug that helps the immune system fight cancer. It is for people with advanced solid tumors, especially certain types of lung cancer or melanoma, who have already tried standard treatments.
This trial tests a new drug called AROG4-01 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to find the right dose and see if the drug can help shrink or slow tumor growth.
This trial tests a new drug called STX-001, which is injected directly into a tumor to help the immune system fight cancer. It is being studied alone or with another immunotherapy (pembrolizumab) for people with advanced solid tumors, including melanoma or triple-negative breast cancer.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.